Hepatitis C treatment experience in a dialysis clinic: nephrologist's perspective

Authors

  • Isabella Navarro da Cruz da Silva
  • Luiza Barranco Omairi
  • Juliana Silva Barbosa
  • Andre Luiz Ciclini
  • Vanessa Cicclini Guerra

Keywords:

Hepatitis C treatment, HCV, renal dialysis, direct acting antivirals, nephrologist

Abstract

Since its discovery in 1989, hepatitis C has been gaining relevance due to its potential to develop into chronic liver disease. It is known that its prevalence is higher in dialysis patients, increasing in accordance with the time the patient remains on treatment. The diagnosis in this population may be difficult because of the nonspecific clinical picture, which may be confused with symptoms of uremia, besides variable levels of alanine aminotransferase (ALT), added to false-negative serologies for hepatitis C virus (HCV) and low viremia. Several studies seek to identify the causes of transmission within dialysis units, and most point to breaches in infection control protocol.

 

DOI: https://doi.org/10.56238/colleinternhealthscienv1-059

Downloads

Published

2023-02-22

Issue

COLLECTION OF INTERNATIONAL TOPICS IN HEALTH SCIENCE- V1

Section

Articles

License

Copyright (c) 2023 Luiza Barranco Omairi, Juliana Silva Barbosa, Andre Luiz Ciclini, Vanessa Cicclini Guerra

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Hepatitis C treatment experience in a dialysis clinic: nephrologist’s perspective. (2023). Seven Editora, 739-741. https://sevenpublicacoes.com.br/editora/article/view/249